Search clinical trials for: aromatase inhibitors (letrozole, anastrozole)
Total 1065 results
-
National University Hospital, SingaporeEisai Co., Ltd.Recruiting
-
Novartis PharmaceuticalsRecruitingMetastatic Breast CancerUnited States, Lebanon, Hong Kong, Turkey, Vietnam, Brazil, Italy, South Africa, Korea, Republic of, Poland, Taiwan, Singapore, Japan, Spain, Costa Rica, Greece, Portugal, Argentina, Mexico
-
SCRI Development Innovations, LLCNovartisCompleted
-
Memorial Sloan Kettering Cancer CenterContext Therapeutics Inc.Active, not recruitingGranulosa Cell Ovarian Cancer | Low Grade Serous Ovarian/ Primary Peritoneal Cancer | Endometrioid Endometrial CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedBreast CancerUnited States
-
Samsung Medical CenterAsan Medical Center; Seoul National University Hospital; Ulsan University Hospital and other collaboratorsUnknownMetastatic Breast Cancer | Estrogen Receptor Positive Tumor | Breast Cancer Nos PremenopausalKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; Novartis Pharmaceuticals; University of California,... and other collaboratorsCompletedFibrolamellar Carcinoma | Fibrolamellar Liver CancerUnited States
-
Hongxia MaRecruitingPolycystic Ovary SyndromeChina
-
AstraZenecaCompletedProgression-free SurvivalKorea, Republic of
-
ETOP IBCSG Partners FoundationBreast International GroupCompletedBreast CancerFrance, Spain, Switzerland, Australia, Belgium, Austria, Peru, Germany, Italy, Japan, New Zealand, Sweden, Denmark, India, United States, Chile, Russian Federation, United Kingdom, Hungary, South Africa
-
Institut fuer FrauengesundheitNovartis; ClinSolUnknownis to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.Germany
-
Yale UniversityUniversity of Colorado, Denver; Eunice Kennedy Shriver National Institute of... and other collaboratorsCompletedPregnancy | Unexplained InfertilityUnited States
-
Stanford UniversityAstraZenecaCompletedBreast CancerUnited States
-
University of Maryland, BaltimoreGlaxoSmithKline; Novartis PharmaceuticalsTerminatedBreast Neoplasms | Neoplasm Metastasis | Endocrine Breast DiseasesUnited States
-
University Hospital, AkershusVestre Viken Hospital Trust; NovartisRecruitingBreast Cancer | Locally Advanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Luminal A Breast Cancer | Luminal B Breast CancerNorway
-
Ahon Pharmaceutical Co., Ltd.Affiliated Hospital of Hebei University; The First Hospital of Jilin University and other collaboratorsRecruiting
-
Mỹ Đức HospitalRecruitingHormone Replacement Therapy | Embryo Transfer | Letrozole | Irregular MenstruationVietnam
-
EQRx, Inc.TerminatedAdvanced Breast CancerUnited States, Georgia, Belgium, Italy, Mexico, Moldova, Republic of
-
Al-Mustansiriyah UniversityAl-Nahrain UniversityCompletedInfertility, Male | Male Reproductive ProblemIraq
-
Mansoura UniversityZagazig UniversityUnknown
-
Mylan Pharmaceuticals IncCompleted
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Massachusetts General HospitalGenentech, Inc.Active, not recruiting
-
AstraZenecaCompleted
-
MedSIRPfizerCompletedBreast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain, Germany, France, United Kingdom, Italy, Slovenia
-
National Institute of Dental and Craniofacial Research...CompletedPrecocious Puberty | McCune Albright Syndrome | Polyostotic Fibrous DysplasiaUnited States
-
Novartis PharmaceuticalsCompletedLocally Advanced Breast CancerBrazil
-
Novartis PharmaceuticalsTerminated
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham...UnknownBreast Cancer | Post-MenopausalUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Completed
-
Hebei Medical University Fourth HospitalNot yet recruiting
-
Gynecologic Oncology GroupEli Lilly and CompanyActive, not recruiting
-
Erasme University HospitalActive, not recruiting
-
Dartmouth-Hitchcock Medical CenterCompletedBreast CancerUnited States
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
Institut Cancerologie de l'OuestRecruitingMastectomy | Ductal Carcinoma in Situ | Extensive DiseaseFrance
-
Millennium Wellness LLCCompleted
-
Peking Union Medical College HospitalUnknownFemale Breast CancerChina
-
AstraZenecaCompleted
-
Fudan UniversityRecruiting
-
Tianjin Hemay Pharmaceutical Co., LtdCompleted
-
Mansoura University HospitalCompleted
-
Novartis PharmaceuticalsCompletedSevere and Recurrent Endometriosis
-
NovartisCompletedMetastatic Breast CancerGermany
-
Novartis PharmaceuticalsCompleted
-
Weill Medical College of Cornell UniversityRecruiting
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
University of Colorado, DenverPfizer; Criterium, Inc.; Cascadian Therapeutics Inc.CompletedBreast CancerUnited States
-
Istituti Clinici Scientifici Maugeri SpACompletedFemale | Neoplasm Malignant | BreastItaly
-
National Cancer Centre, SingaporeMSD Pharma (Singapore) Pte LtdRecruitingHormone Receptor-Positive HER2-Negative Advanced Breast CancerSingapore